Table 1 Characteristics of practices included in the analysis (from January 2018 to December 2018).

From: A retrospective database study of oral corticosteroid and bisphosphonate prescribing patterns in England

 

Median

IQR

Asthma prevalence (%)

6.0

5.1–6.8

COPD prevalence (%)

1.8

1.3–2.5

Practice list size

7478

4664–11,270

Patients with long-term health conditions (%)

51.7

45.5–59.1

Patients over 65 years old (%)

17.4

12.2–21.8

Quality Outcomes Framework score

549.0

534.7–556.8

OCS prescribed items per 1000 patients

120.8

84.8–160.4

BP prescribed items per 1000 patients

107.7

73.8–147.4

  1. COPD chronic obstructive pulmonary disease, OCS oral corticosteroids, BP bisphosphonates.